Mechanisms of anti-GPIba antibody-induced thrombocytopenia in mice

Yosuke Morodomi, Sachiko Kanaji, Eric Won, Zaverio M. Ruggeri, Taisuke Kanaji

Research output: Contribution to journalArticlepeer-review

19 Citations (Scopus)


Immune thrombocytopenia (ITP) is an acquired bleeding disorder characterized by antibody-mediated platelet destruction. Different mechanisms have been suggested to explain accelerated platelet clearance and impaired thrombopoiesis, but the pathophysiology of ITP has yet to be fully delineated. In this study, we tested 2 mouse models of immune-mediated thrombocytopenia using the rat anti-mouse GPIba monoclonal antibody 5A7, generated in our laboratory. After a single IV administration of high-dose (2 mg/kg) 5A7, opsonized platelets were rapidly cleared from the circulation into the spleen and liver; this was associated with rapid upregulation of thrombopoietin (TPO) messenger RNA. In contrast, subcutaneous administration of low-dose 5A7 (0.08-0.16 mg/kg) every 3 days gradually lowered the platelet count; in this case, opsonized platelets were observed only in the spleen, and TPO levels remained unaltered. Interestingly, in both models, the 5A7 antibody was found on the surface of, as well as internalized to, bone marrow megakaryocytes. Consequently, platelets generated in the chronic phase of repeated subcutaneous 5A7 administration model showed reduced GPIba membrane expression on their surface. Our findings indicate that evaluation of platelet surface GPIba relative to platelet size may be a useful marker to support the diagnosis of anti-GPIba antibody-induced ITP.

Original languageEnglish
Pages (from-to)2292-2301
Number of pages10
Issue number25
Publication statusPublished - Jun 18 2020
Externally publishedYes

All Science Journal Classification (ASJC) codes

  • Biochemistry
  • Immunology
  • Hematology
  • Cell Biology


Dive into the research topics of 'Mechanisms of anti-GPIba antibody-induced thrombocytopenia in mice'. Together they form a unique fingerprint.

Cite this